Oryon Cell Therapies: Funding, Investors & Team (Sep 2026)
Oryon Cell treatments is a clinical-stage biotechnology business exploring autologous cell treatments for neurodegenerative illnesses, first focusing on Parkinson's disease.
Oryon Cell Therapies has raised $21.0M across 1 funding round on record, the most recent a Series A of $21.0M announced in Mar 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Oryon Cell Therapies Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Oryon Cell Therapies Funding Rounds
Oryon Cell Therapies Founders and Leadership Team
Contact details for the Oryon Cell Therapies team: 1 has a LinkedIn profile.
Start 14-day free trial →Oryon Cell Therapies Funding Compared to Other Biotechnology Startups
Oryon Cell Therapies' latest round of $21.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Biotechnology Startups Like Oryon Cell Therapies
Companies Similar to Oryon Cell Therapies
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Wren Bioscience is developed to give rapid, reliable bacterial identification anywhere milk safety is…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Oryon Cell Therapies Funding FAQs
What does Oryon Cell Therapies do?
Oryon Cell treatments is a clinical-stage biotechnology business exploring autologous cell treatments for neurodegenerative illnesses, first focusing on Parkinson's disease.
How much funding has Oryon Cell Therapies raised?
Oryon Cell Therapies has raised $21.0M across 1 round on record. The most recent is a Series A of $21.0M announced in Mar 2026.
When did Oryon Cell Therapies last raise funding?
Oryon Cell Therapies' most recent funding round on record is a Series A of $21.0M, announced in Mar 2026.
Who founded Oryon Cell Therapies?
FundedIQ lists Nikola Kojic (Founder) at Oryon Cell Therapies.
How many employees does Oryon Cell Therapies have?
Oryon Cell Therapies is in the 1-10 employee band.
How does Oryon Cell Therapies' funding compare to other Biotechnology startups?
Oryon Cell Therapies' latest round of $21.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Oryon Cell Therapies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oryon Cell Therapies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.